Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01696799Phase 2Completed
Phase 2, randomised, single-blind trial of econazole in interdigital tinea pedis (TP) (3 arms), sponsored by AmDerma Pharmaceuticals. Primary endpoints: Plasma Levels of Econazole Nitrate at 28 days and Investigator Assessment of Response to Treatment at 28 days. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01696799.